Glenn Phillips
Biographic Data
| ID | 3885068 |
|---|---|
| NAME | Glenn Phillips |
| GIVEN NAMES | Glenn |
| FAMILY NAME | Phillips |
| SIGNATURE | PHILLIPS G |
| AFFILIATIONS | Eli Lilly (United States) |
| ORCID | 0000-0002-9676-1909 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 6 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2000 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
“This Show Is So Metal”
A conversation between the three curators of the exhibition Lumen: The Art and Science of Light held at the Getty Museum from 10 September to 8 December 2024 as part of PST ART: Art and Science Collide. Colleagues look back on the planning, technical expertise, and creative collaboration that went into the making and mounting of the exhibition, illuminating the inspirations and surprises that arose along the way
Estimating the minimal clinically important difference for the Myasthenia Gravis Quality of Life revised scale (MG-QOL15R)
To estimate the minimal clinically important difference (MCID) for the MG-QOL15R. Data from two multi-country myasthenia gravis studies were used: the ADAPT RCT (n = 157) and the MyRealWorld-MG (MRW-MG) survey (n = 92). MCIDs were estimated using four anchor-based methods: change difference (CD), receiver operating characteristic (ROC) curve with Area Under the Curve (AUC), linear regression, and equipercentile linking. MG-Activities of Daily Liv…
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity
Introduction: Myasthenia Gravis (MG) is a debilitating autoimmune disorder associated with fatigue and weakness in the ocular, respiratory, bulbar and limb muscles. This study evaluates productivity losses for MG patients and their caregivers by MG symptom severity. Methods: In the multinational MyRealWorld-MG study, 1,049 MG patients and caregivers reported on work productivity (sick leave, reduced working hours, early retirement). Productivity …
Racial disparities in acute care utilization among individuals with myasthenia gravis
Objective: In myasthenia gravis (MG), evidence on the impact of social determinants of health on disparities in disease burden and healthcare resource utilization is limited. This study aimed to investigate the independent association between race/ethnicity and acute care utilization during the 2 years post-diagnosis among patients with MG. Methods: A retrospective cohort study was conducted among adults (≥18 years) with newly diagnosed MG in the…
Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs
Introduction: Social determinants of health (SDOH) are important contributors to health outcomes, and better understanding their impact on individuals diagnosed with rare, chronic diseases with high burden and unmet need is critical. Characterizing SDOH burden can help improve the design of patient support programs (PSPs), using targeted approaches to remove barriers to access. Methods: This study used a mixed-methods strategy employing a quantit…
The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges
Objective: Better understanding the impact of social determinants of health (SDOH) barriers from the patient perspective is crucial to improve holistic patient support in generalized myasthenia gravis (gMG), a rare autoimmune disorder with high disease and treatment burden. The objective of this study was to identify economic challenges experienced by individuals living with gMG and SDOH barriers to better address current unmet needs. Methods: Ad…
The Fatigue Associated with Depression Questionnaire (FAsD)
The FAsD was responsive to change, and the responder definition may be used when interpreting treatment-related change. Results add to previous findings suggesting the FAsD is a useful measure of fatigue among patients with depression
The Center for Epidemiologic Studies Depression Scale With a Young Adolescent Population
The Center for Epidemiological Studies Depression scale (CES-D) was developed to assess the population prevalence of depression. The CES-D was developed and normed on an adult population. Since the CES-D's publication, various studies have both used and psychometrically assessed the scale for older adolescent populations. However, we found no report of the CES-D's psychometric properties for young adolescent populations. We conducted a confirmato…
The effects of psychological therapies under clinically representative conditions
The effects of psychological therapies under clinically representative conditions
The Center for Epidemiologic Studies Depression Scale With a Young Adolescent Population
The Center for Epidemiological Studies Depression scale (CES-D) was developed to assess the population prevalence of depression. The CES-D was developed and normed on an adult population. Since the CES-D's publication, various studies have both used and psychometrically assessed the scale for older adolescent populations. However, we found no report of the CES-D's psychometric properties for young adolescent populations. We conducted a confirmato…
The Fatigue Associated with Depression Questionnaire (FAsD)
The FAsD was responsive to change, and the responder definition may be used when interpreting treatment-related change. Results add to previous findings suggesting the FAsD is a useful measure of fatigue among patients with depression
Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs
Introduction: Social determinants of health (SDOH) are important contributors to health outcomes, and better understanding their impact on individuals diagnosed with rare, chronic diseases with high burden and unmet need is critical. Characterizing SDOH burden can help improve the design of patient support programs (PSPs), using targeted approaches to remove barriers to access. Methods: This study used a mixed-methods strategy employing a quantit…
The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges
Objective: Better understanding the impact of social determinants of health (SDOH) barriers from the patient perspective is crucial to improve holistic patient support in generalized myasthenia gravis (gMG), a rare autoimmune disorder with high disease and treatment burden. The objective of this study was to identify economic challenges experienced by individuals living with gMG and SDOH barriers to better address current unmet needs. Methods: Ad…
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity
Introduction: Myasthenia Gravis (MG) is a debilitating autoimmune disorder associated with fatigue and weakness in the ocular, respiratory, bulbar and limb muscles. This study evaluates productivity losses for MG patients and their caregivers by MG symptom severity. Methods: In the multinational MyRealWorld-MG study, 1,049 MG patients and caregivers reported on work productivity (sick leave, reduced working hours, early retirement). Productivity …
Racial disparities in acute care utilization among individuals with myasthenia gravis
Objective: In myasthenia gravis (MG), evidence on the impact of social determinants of health on disparities in disease burden and healthcare resource utilization is limited. This study aimed to investigate the independent association between race/ethnicity and acute care utilization during the 2 years post-diagnosis among patients with MG. Methods: A retrospective cohort study was conducted among adults (≥18 years) with newly diagnosed MG in the…
“This Show Is So Metal”
A conversation between the three curators of the exhibition Lumen: The Art and Science of Light held at the Getty Museum from 10 September to 8 December 2024 as part of PST ART: Art and Science Collide. Colleagues look back on the planning, technical expertise, and creative collaboration that went into the making and mounting of the exhibition, illuminating the inspirations and surprises that arose along the way
Estimating the minimal clinically important difference for the Myasthenia Gravis Quality of Life revised scale (MG-QOL15R)
To estimate the minimal clinically important difference (MCID) for the MG-QOL15R. Data from two multi-country myasthenia gravis studies were used: the ADAPT RCT (n = 157) and the MyRealWorld-MG (MRW-MG) survey (n = 92). MCIDs were estimated using four anchor-based methods: change difference (CD), receiver operating characteristic (ROC) curve with Area Under the Curve (AUC), linear regression, and equipercentile linking. MG-Activities of Daily Liv…
Medicine (6 works) · Myasthenia Gravis and Thymoma (5 works) · Gerontology (4 works) · Psychology (4 works) · Public health (4 works) · Adrenal Hormones and Disorders (3 works) · Clinical Psychology (3 works) · Fibromyalgia and Chronic Fatigue Syndrome Research (3 works) · Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 works) · Demography (2 works)